• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 MDA5 抗体阳性皮肌炎患者死亡的风险因素:荟萃分析和系统评价。

Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: A meta-analysis and systematic review.

机构信息

Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan Wangfujing, Dongcheng District, Beijing, China; Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan Wangfujing, Dongcheng District, Beijing, China.

Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan Wangfujing, Dongcheng District, Beijing, China.

出版信息

Semin Arthritis Rheum. 2023 Oct;62:152231. doi: 10.1016/j.semarthrit.2023.152231. Epub 2023 Jun 9.

DOI:10.1016/j.semarthrit.2023.152231
PMID:37348186
Abstract

OBJECTIVES

To determine the prognostic factors of dermatomyositis with anti-melanoma differentiation-associated gene 5 (MDA5) antibody, a rare disease and often complicated by life-threatening, rapidly progressive interstitial lung disease.

METHODS

Herein, we searched the Medline, Embase, and Cochrane Library databases and extracted studies published before August 23, 2022. Pooled analysis of hazard ratios (HRs) or odds ratios was used to identify prognostic factors for mortality among patients with anti-MDA5 antibody-positive dermatomyositis (MDA5+ DM).

RESULTS

Twenty-nine cohorts with 2,645 patients were included in this meta-analysis. Factors related to poor prognosis included old age (HR 1.54, 95% confidence interval (CI) 1.41-1.69, p < 0.01), male sex (HR 2.07, 95% CI 1.34-3.18, p < 0.01), rapidly progressive interstitial lung disease (RP-ILD) (HR 9.34, 95% CI 6.39-13.6, p < 0.01), high levels of ferritin (HR 1.05, 95% CI 1.01-1.08, p < 0.01), C-reactive protein (CRP) (HR 1.12, 95% CI 1.06-1.19, p < 0.01), creatine kinase (HR 1.05, 95% CI 1.03-1.07, p < 0.01), and lactate dehydrogenase (LDH) (HR 1.27, 95% CI 1.12-1.45, p < 0.01), whereas oxygen index (HR 0.990, 95% CI 0.988-0.992, p < 0.01), partial pressure of oxygen (HR 0.933, 95% CI 0.906-0.961, p < 0.01), forced vital capacity (HR 0.962, 95% CI 0.928-0.998, p = 0.038), and lymphocyte count (HR 0.421, 95% CI 0.282-0.629, p < 0.01) were associated with better outcomes.

CONCLUSIONS

Old age, male sex, hypoxemia, low forced vital capacity, lymphocytopenia, and high levels of ferritin, CRP, creatine kinase, and LDH are risk factors for mortality in patients with MDA5+ DM. However, a cautious interpretation of these results and further quality investigation are warranted.

摘要

目的

确定抗黑色素瘤分化相关基因 5(MDA5)抗体阳性皮肌炎(MDA5+ DM)的预后因素,MDA5+ DM 是一种罕见疾病,常伴有危及生命的快速进展性间质性肺病。

方法

本研究检索了 Medline、Embase 和 Cochrane Library 数据库,并提取了截至 2022 年 8 月 23 日发表的研究。使用风险比(HR)或优势比的汇总分析来确定 MDA5+ DM 患者死亡的预后因素。

结果

本 meta 分析共纳入了 29 项队列研究,共 2645 例患者。与预后不良相关的因素包括年龄较大(HR 1.54,95%置信区间(CI)1.41-1.69,p < 0.01)、男性(HR 2.07,95%CI 1.34-3.18,p < 0.01)、快速进展性间质性肺病(RP-ILD)(HR 9.34,95%CI 6.39-13.6,p < 0.01)、铁蛋白水平较高(HR 1.05,95%CI 1.01-1.08,p < 0.01)、C 反应蛋白(CRP)(HR 1.12,95%CI 1.06-1.19,p < 0.01)、肌酸激酶(HR 1.05,95%CI 1.03-1.07,p < 0.01)和乳酸脱氢酶(LDH)(HR 1.27,95%CI 1.12-1.45,p < 0.01),而氧指数(HR 0.990,95%CI 0.988-0.992,p < 0.01)、氧分压(HR 0.933,95%CI 0.906-0.961,p < 0.01)、用力肺活量(HR 0.962,95%CI 0.928-0.998,p = 0.038)和淋巴细胞计数(HR 0.421,95%CI 0.282-0.629,p < 0.01)与较好的预后相关。

结论

年龄较大、男性、低氧血症、用力肺活量低、淋巴细胞减少以及铁蛋白、CRP、肌酸激酶和 LDH 水平较高是 MDA5+ DM 患者死亡的危险因素。然而,需要谨慎解释这些结果并进一步进行质量调查。

相似文献

1
Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: A meta-analysis and systematic review.抗 MDA5 抗体阳性皮肌炎患者死亡的风险因素:荟萃分析和系统评价。
Semin Arthritis Rheum. 2023 Oct;62:152231. doi: 10.1016/j.semarthrit.2023.152231. Epub 2023 Jun 9.
2
Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome.抗MDA5阳性皮肌炎和抗合成酶综合征中快速进展性间质性肺病的不同多变量危险因素。
Front Immunol. 2022 Mar 7;13:845988. doi: 10.3389/fimmu.2022.845988. eCollection 2022.
3
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.抗 MDA5 抗体阳性皮肌炎相关间质性肺病患者血清几丁质酶水平的临床意义。
J Rheumatol. 2019 Aug;46(8):935-942. doi: 10.3899/jrheum.180825. Epub 2019 May 15.
4
Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.抗黑色素瘤分化相关基因5抗体低阳性滴度与皮肌炎患者间质性肺病的长期不良预后无关。
Respir Investig. 2018 Nov;56(6):464-472. doi: 10.1016/j.resinv.2018.07.007. Epub 2018 Aug 24.
5
Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.抗黑色素瘤分化相关基因5抗体阳性皮肌炎合并快速进展性间质性肺病的临床特征及不良预后因素
Eur J Dermatol. 2019 Oct 1;29(5):511-517. doi: 10.1684/ejd.2019.3634.
6
[Clinical characteristics and prognostic factors of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated interstitial lung disease].抗黑色素瘤分化相关基因5抗体阳性皮肌炎相关间质性肺疾病患者的临床特征及预后因素
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Aug 12;46(8):781-790. doi: 10.3760/cma.j.cn112147-20221017-00821.
7
Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis.抗黑色素瘤分化相关蛋白 5 抗体相关性皮肌炎患者快速进展性间质性肺病和死亡率的预测因素。
Rheumatology (Oxford). 2022 Nov 2;61(11):4437-4444. doi: 10.1093/rheumatology/keac094.
8
Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.多发性肌炎/皮肌炎相关间质性肺疾病中肌炎特异性自身抗体的综合评估
Respir Med. 2016 Dec;121:91-99. doi: 10.1016/j.rmed.2016.10.019. Epub 2016 Nov 2.
9
Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.加拿大抗黑色素瘤分化相关基因 5(MDA5)阳性皮肌炎患者的临床特征和治疗:基于病例的回顾性研究。
Rheumatol Int. 2019 Nov;39(11):1971-1981. doi: 10.1007/s00296-019-04398-2. Epub 2019 Aug 2.
10
Elevated serum B-cell activator factor levels predict rapid progressive interstitial lung disease in anti-melanoma differentiation associated protein 5 antibody positive dermatomyositis.血清 B 细胞激活因子水平升高可预测抗黑色素瘤分化相关蛋白 5 抗体阳性皮肌炎的快速进展性间质性肺病。
Orphanet J Rare Dis. 2024 Apr 19;19(1):170. doi: 10.1186/s13023-024-03153-6.

引用本文的文献

1
The feature and significance of lower limb MRI in adult myositis patients with anti-NXP2 antibody: a retrospective cohort study in China.抗NXP2抗体成人肌炎患者下肢MRI的特征及意义:一项中国的回顾性队列研究
Front Med (Lausanne). 2025 Aug 25;12:1581902. doi: 10.3389/fmed.2025.1581902. eCollection 2025.
2
A pilot transcriptomic study of a novel multitargeted BRT regimen for anti-MDA5 antibody-positive dermatomyositis: improving survival over conventional therapy.一项针对抗MDA5抗体阳性皮肌炎的新型多靶点BRT方案的初步转录组学研究:与传统疗法相比提高生存率。
Front Immunol. 2025 Aug 7;16:1568338. doi: 10.3389/fimmu.2025.1568338. eCollection 2025.
3
Clinical characteristics and outcomes of anti-MDA5 dermatomyositis: a retrospective study.
抗MDA5皮肌炎的临床特征与结局:一项回顾性研究
BMC Rheumatol. 2025 Aug 18;9(1):102. doi: 10.1186/s41927-025-00556-1.
4
Risk factors for mortality in anti-MDA5 antibody-positive dermatomyositis with interstitial lung disease: a systematic review and meta-analysis.抗MDA5抗体阳性皮肌炎合并间质性肺病患者死亡的危险因素:一项系统评价和荟萃分析
Front Immunol. 2025 Jul 17;16:1628748. doi: 10.3389/fimmu.2025.1628748. eCollection 2025.
5
Coexistence of anti-melanoma differentiation-associated protein 5 and anti-Ro52 antibodies in patients with idiopathic inflammatory myopathy: a retrospective cohort study.特发性炎性肌病患者中抗黑色素瘤分化相关蛋白5抗体与抗Ro52抗体的共存:一项回顾性队列研究
Clin Rheumatol. 2025 Jul 15. doi: 10.1007/s10067-025-07562-1.
6
Serum ferritin as a specific biomarker of anti-MDA5-interstitial lung disease: a multicenter, case-control study in observational and validation datasets.血清铁蛋白作为抗MDA5间质性肺病的特异性生物标志物:一项在观察性和验证性数据集中开展的多中心病例对照研究
Rheumatol Int. 2025 Jul 15;45(8):171. doi: 10.1007/s00296-025-05918-z.
7
Slowly Progressive Melanoma Differentiation-Associated Gene 5 (MDA-5) Interstitial Lung Disease Following COVID-19 Infections: A Pulmonary Puzzle.新冠病毒感染后缓慢进展的黑色素瘤分化相关基因5(MDA-5)间质性肺疾病:一个肺部难题。
Cureus. 2025 Apr 1;17(4):e81584. doi: 10.7759/cureus.81584. eCollection 2025 Apr.
8
Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis.识别抗MDA5抗体患者预后不良的两条途径:来自预后因素和细胞因子分析的见解
Arthritis Res Ther. 2025 Apr 16;27(1):89. doi: 10.1186/s13075-025-03558-z.
9
Mortality Risk Prediction in Patients With Antimelanoma Differentiation-Associated, Gene 5 Antibody-Positive, Dermatomyositis-Associated Interstitial Lung Disease: Algorithm Development and Validation.抗黑色素瘤分化相关基因5抗体阳性、皮肌炎相关间质性肺疾病患者的死亡风险预测:算法开发与验证
J Med Internet Res. 2025 Feb 5;27:e62836. doi: 10.2196/62836.
10
Clinical features and prognosis of anti-MDA5-positive dermatomyositis with coexistent anti-aminoacyl-tRNA synthetase antibodies.合并抗氨酰tRNA合成酶抗体的抗MDA5阳性皮肌炎的临床特征及预后
Clin Rheumatol. 2025 Feb;44(2):767-774. doi: 10.1007/s10067-024-07298-4. Epub 2025 Jan 3.